Bausch Health Companies Inc.

Company Overview

Bausch Health Companies Inc. manufactures a broad range of generic and branded pharmaceuticals, over-the-counter products, and medical devices, including ophthalmic, surgical, and aesthetic devices. It develops, manufactures, and markets a diverse portfolio of products across various therapeutic areas, including gastroenterology, hepatology, neurology, dermatology, and medical aesthetic devices. It operates in five segments - Salix, International, Solta Medical, Bausch + Lomb, and Diversified Products. Bausch Health offers medical aesthetic devices through its Solta Medical division.

Bausch Health Companies Inc. operates in over 90 countries across North America, Europe, the Middle East, Africa, Asia Pacific, and Latin America. It offers both branded and generic pharmaceuticals, as well as over-the-counter (OTC) products, to address the evolving demands of the global healthcare market.

Financial Highlights (FY 2025)

Company's Business Segments

• Salix : The Salix segment consists of sales in the U.S. of GI products like Sales of Xifaxan, Others.
• International : The International segment consists of sales, except for sales of Bausch + Lomb products, Solta Medical aesthetic medical devices, outside the U.S. and Puerto Rico of branded Pharmaceutical products, branded Generic pharmaceutical products, OTC products.
• Solta Medical : The Solta Medical segment consists of global Solta Medical Aesthetic medical device sales.
• Diversified : The Diversified segment consists of sales in the U.S. of Pharmaceutical products in Neurology, certain other Therapeutic classes, Dermatology products, Generic pharmaceutical products, Dentistry products.
• Bausch + Lomb : The Bausch + Lomb segment consists of global sales of Bausch + Lomb Vision Care, Surgical, Pharmaceuticals products.